Leveraging immunoliposomes as nanocarriers against SARS-CoV-2 and its emerging variants

Leveraging immunoliposomes as nanocarriers against SARS-CoV-2 and its emerging variants

The global COVID-19 pandemic arising from SARS-CoV-2 has impacted many lives, gaining interest worldwide ever since it was first identified in December 2019. Till 2023, 752 million cumulative cases and 6.8 million deaths were documented globally. COVID-19 has been rapidly evolving, affecting virus t...

Full description

Bibliographic Details
Main Authors: Nur Dini Fatini Mohammad Faizal, Nurul Afina Ramli, Nur Najihah Izzati Mat Rani, Nur Adania Shaibie, Aarti, Pattaporn Poonsawas, Sunil K. Sharma, Mohd Cairul Iqbal Mohd Amin
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Asian Journal of Pharmaceutical Sciences
Subjects:
Coronavirus
COVID-19
SARS-CoV-2
Liposomes
Immunoliposomes
Online Access:http://www.sciencedirect.com/science/article/pii/S181808762300082X

Internet

http://www.sciencedirect.com/science/article/pii/S181808762300082X

Similar Items